Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicon ; 224: 107034, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-36690088

ABSTRACT

Warnings of neurotoxic respiratory paralysis following envenomation by rattlesnakes (Crotalus sp.) have been included in numerous scholarly publications over the past 60 years, resulting in fear and anxiety in the public and among clinicians. We examine the validity of the widespread belief that rattlesnakes in the arid southwestern United States, and particularly the Mohave Rattlesnake (Crotalus scutulatus), pose a significant risk of medically relevant respiratory weakness and paralysis in humans. A retrospective review of 3440 suspected rattlesnake bites reported to the Arizona Poison and Drug Information Center between 1999 and 2020 produced no evidence of respiratory weakness in a region with three species known to express significant amounts of neurotoxin in their venoms: Crotalus concolor, C. tigris, and the more widely distributed C. scutulatus. A literature review produced numerous warnings regarding respiratory paralysis following envenomation by rattlesnakes in our region that either lacked references or cited sources that did not contain strong supportive data. We found no case reports of neurotoxic respiratory weakness following Arizona rattlesnake bites in the literature and such reports in surrounding states were scant. We conclude that neurotoxic respiratory failure in this region following rattlesnake envenomation is extraordinarily rare. All rattlesnake bites should receive the same consideration and critical care, and warnings about significant risk of respiratory failure are unwarranted, regardless of species involved.


Subject(s)
Crotalid Venoms , Neurotoxicity Syndromes , Respiratory Paralysis , Snake Bites , Humans , Animals , Crotalus , Arizona , Crotalid Venoms/toxicity
2.
Clin Toxicol (Phila) ; 59(11): 1009-1014, 2021 11.
Article in English | MEDLINE | ID: mdl-33755514

ABSTRACT

BACKGROUND: The advent of COVID-19 increased attention to hand hygiene in prevention of disease transmission. To meet the increased demand for hand sanitizer during the pandemic, the US FDA issued an Emergency Use Authorization allowing new manufacturers and importers to enter the market. Some of the newly introduced hand sanitizer products contained methanol in lieu of ethanol or isopropanol. We describe five patients with fatal methanol poisoning resulting from hand sanitizers improperly containing methanol. CASE SUMMARY: Comparing a 5-month period from 2019 to the same time frame in 2020, the Arizona Poison and Drug Information Center has seen an increase of 124% in exposures to hand sanitizer. Of these cases, 28% involved methanol-contaminated hand sanitizer. Five of these patients died from methanol poisoning. All five cases had similar clinical features with severe high anion gap metabolic acidosis and, in four patients, elevated osmolal gap. Methanol concentrations were consistently very elevated, but these results were not available before the patients succumbed. Four of the patients received fomepizole and adjunctive care. Two patients received emergency extracorporeal therapy. All five died despite maximal treatment efforts. CONCLUSION: During the pandemic in 2020, there was a proliferation of alcohol-based hand sanitizers which contained methanol. Exposure to these products, which failed to meet regulatory standards, led to increased harm and death. Challenges to treatment of methanol poisoning, especially in rural areas, include lack of access to timely laboratory measurement of methanol concentrations and lack of available emergency hemodialysis without transfer of the patient.


Subject(s)
COVID-19 , Hand Sanitizers/poisoning , Methanol/poisoning , Poisoning/etiology , Adult , Arizona/epidemiology , Female , Hand Sanitizers/chemistry , Humans , Male , Middle Aged , Poison Control Centers/statistics & numerical data , Poisoning/therapy , Syndemic
4.
J Pediatr ; 196: 314-317.e1, 2018 05.
Article in English | MEDLINE | ID: mdl-29395180

ABSTRACT

A 17-month-old child presented with hypertension, fussiness, constipation, and arthralgia due to mercury toxicity from a skin-lightening cosmetic used by her mother and grandmother. Blood mercury level was 26 mcg/L and urine level was 243 mcg/g creatinine. She was chelated with succimer. The home was contaminated and needed remediation.


Subject(s)
Chelating Agents/therapeutic use , Mercury Poisoning/diagnosis , Skin Lightening Preparations/adverse effects , Succimer/therapeutic use , Environmental Restoration and Remediation/methods , Female , Humans , Infant , Mercury/blood , Mercury/urine , Mercury Poisoning/drug therapy , Mercury Poisoning/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...